United States · FDA National Drug Code directory
ERY-TAB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24338-124_f7f33758-f601-4397-baa4-30286a9a3a39
- Product NDC
- 24338-124
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Erythromycin
- Labeler
- Arbor Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110418
- Source listing expiry
- 20261231
Source-listed ingredients
- ERYTHROMYCIN — 333 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-124-03) · 24338-124-03
- 100 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-124-13) · 24338-124-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →